The “Ubiquitous Pharmacogenomics” project (U-PGx) to establish a firm foundation for ‘Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen’.
The European Union H2020 programme has awarded a €15 million grant to the Ubiquitous Pharmacogenomics (U-PGx) consortium. The Medical University of Vienna plays a key role in the project, which will implement pharmacogenomic testing and computer-based decision support for 8,000 patients in 7 European countries to investigate whether this emerging approach is cost-effective and results in better patient outcomes.
MedUni Vienna Researchers
Assoc.-Prof. Dr. Matthias Samwald
Center for Medical Statistics, Informatics and Intelligent Systems
Section for Artificial Intelligence and Decision Support
matthias.samwald@meduniwien.ac.at
Research Staff
Dr. Kathrin Blagec
Project Team Members
Ao. Univ.-Prof. Dr. Gere Sunder-Plassmann
Ao. Univ. Prof. Dr. Alice Schmidt
Assoz. Prof. Dr. Gürkan Sengoelge
Department of Medicine III, Division of Nephrology and Dialysis
Consortium
16 project participants
Coordinator: Prof. Dr. Henk-Jan Guchelaar, Leiden University Medical Center, the Netherlands
Facts
| Programme | H2020 |
|---|---|
| Call/Topic | PHC-24-2015: Piloting personalised medicine in health and care systems |
| Project duration | 01.01.2016 - 31.12.2020 |
| EU contribution – MedUni Vienna | € 1.429.783 |
| EC contribution – total project | € 14.936.613 |
